source
- Two Massachusetts biotech firms shut down, ending cancer and eye‑disease programsAdecto Pharmaceuticals, a Boston‑based biotech developing a treatment for cancers resistant to standard immunotherapy, announced it has ceased operations as of September 30. CEO Nora Minerva shared…
- Energy drinks partner with college sports, raising safety concerns for teensKent Sepkowitz, a professor emeritus at Weill‑Cornell Medical College, writes that energy drinks have grown into an $85‑billion global market and are now being marketed alongside college sports pro…